Skip to content

ABS Breast Surgeons' Screening Survey

The Clinical Practice & Standards Committee would like to ask all consultant surgeon members to complete this short survey looking at how patients with screen detected cancers are diagnosed in your breast unit and what localisation methods are being used. It should not take more than 5 minutes to complete, so we would be very grateful if you could take part. We would ask you to include your name and hospital so that we can identify submissions from the same unit when analysing the data.
1.Name:
2.Hospital:
3.Who normally gives the core biopsy results for screen-detected cancers in your unit?
4.Is the cancer diagnosis given to the patient in the screening unit or in your hospital?
5.Is there a Consultant Breast Surgeon present in your screening MDT?
6.Approximately how many screening referrals does your unit see each year?
7.Approximately how many screening referrals are treated under your name per year?
8.Which is your main localisation method of choice for impalpable cancers?
9.Which sentinel node biopsy localisation do you predominantly use?
10.Do you offer Magtrace marking of sentinel lymph nodes for patients undergoing mastectomies for DCIS?
11.Do you routinely use both Magtrace to identify the sentinel lymph node and Magseed to localise the tumour in cases where the breast cancer is impalpable?